1. Biblio

Biblio

Found 81 results
Author [ Title(Desc)] Type Year
Filters: Author is William H. Bisson  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
A. Carnero, Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. Fernando, Mondello, C., A Scovassi, I., Bisson, W. H., Amedei, A., Roy, R., and Bisson, W. H., “Disruptive chemicals, senescence and immortality”, Carcinogenesis, vol. 36, pp. S19–S37, 2015.
K. Badri Narayanan, Ali, M., Barclay, B. J., Cheng, Q. Shawn, D’Abronzo, L., Dornetshuber-Fleiss, R., Ghosh, P. M., Guzman, M. J. Gonzalez, Lee, T. - J., Leung, P. Sing, and Bisson, W. H., “Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death”, Carcinogenesis, vol. 36, pp. S89–S110, 2015.
T. D. Hubbard, Murray, I. A., Bisson, W. H., Sullivan, A. P., Sebastian, A., Perry, G. H., Jablonski, N. G., and Perdew, G. H., “Divergent Ah receptor ligand selectivity during hominin evolution.”, Mol Biol Evol, 2016.
W. H. Bisson, “Drug repurposing in chemical genomics: can we learn from the past to improve the future?”, Current topics in medicinal chemistry, vol. 12, pp. 1883–1888, 2012.
E
W. H. Bisson, “Editorial: computational chemogenomics in drug design and discovery.”, Current topics in medicinal chemistry, vol. 12, p. 1867, 2012.
P. A. Thompson, Khatami, M., Baglole, C. J., Sun, J., Harris, S. A., Moon, E. - Y., Al-Mulla, F., Al-Temaimi, R., Brown, D. G., Colacci, A. Maria, and Bisson, W. H., “Environmental immune disruptors, inflammation and cancer risk”, Carcinogenesis, vol. 36, pp. S232–S253, 2015.
W. H. Bisson, “Environmental immune disruptors, inflammation and carcinogenesis: A state of the science and new horizons”, Toxicology Letters, vol. 280, pp. S9 - S10, 2017.
A. D. Benninghoff, Bisson, W. H., Koch, D. C., Ehresman, D. J., Kolluri, S., and Williams, D. E., “Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro”, Toxicological sciences, p. kfq379, 2010.
B. C. Brinchmann, Le Ferrec, E., Bisson, W. H., Podechard, N., Huitfeldt, H. S., Gallais, I., Sergent, O., Holme, ørnA., Lagadic-Gossmann, D., and Øvrevik, J., “Evidence of selective activation of aryl hydrocarbon receptor nongenomic calcium signaling by pyrene”, Biochemical Pharmacology, vol. 158, pp. 1 - 12, 2018.
F
M. Crisma, Bisson, W. H., Formaggio, F., Broxterman, Q. B., and Toniolo, C., “Factors governing 310-helix vs $\alpha$-helix formation in peptides: Percentage of C$\alpha$-tetrasubstituted $\alpha$-amino acid residues and sequence dependence”, Biopolymers, vol. 64, pp. 236–245, 2002.
G
L. Sun, Xie, C., Wang, G., Wu, Y., Wu, Q., Wang, X., Liu, J., Deng, Y., Xia, J., Chen, B., Zhang, S., Yun, C., Lian, G., Zhang, X., Zhang, H., Bisson, W. H., Shi, J., Gao, X., Ge, P., Liu, C., Krausz, K. W., Nichols, R. G., Cai, J., Rimal, B., Patterson, A. D., Wang, X., Gonzalez, F. J., and Jiang, C., “Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.”, Nat Med, 2018.
H
P. Rajendran, Kidane, A. I., Yu, T. - W., Dashwood, W. - M., Bisson, W. H., Löhr, C. V., Ho, E., Williams, D. E., and Dashwood, R. H., “HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates”, Epigenetics, vol. 8, pp. 612–623, 2013.
Y. Kang, Nian, H., Rajendran, P., Kim, E., Dashwood, W. M., Pinto, J. T., Boardman, L. A., Thibodeau, S. N., Limburg, P. J., Löhr, C. V., and Bisson, W. H., “HDAC8 and STAT3 repress BMF gene activity in colon cancer cells”, Cell death & disease, vol. 5, p. e1476, 2014.
E. Kim, Bisson, W. H., Löhr, C. V., Williams, D. E., Ho, E., Dashwood, R. H., and Rajendran, P., “Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.”, Curr Top Med Chem, vol. 16, no. 7, pp. 714-31, 2016.
W. H. Bisson, Westera, G., P Schubiger, A., and Scapozza, L., “Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes $\alpha$4$\beta$2 and $\alpha$7”, Journal of molecular modeling, vol. 14, pp. 891–899, 2008.
I
K. J. Smith, Murray, I. A., Tanos, R., Tellew, J., Boitano, A. E., Bisson, W. H., Kolluri, S., Cooke, M. P., and Perdew, G. H., “Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism”, Journal of Pharmacology and Experimental Therapeutics, vol. 338, pp. 318–327, 2011.
H. Sang Jang, Pearce, M. C., O'Donnell, E. F., Nguyen, B. Duc, Truong, L., Mueller, M. J., Bisson, W. H., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells.”, Biology (Basel), vol. 6, no. 4, 2017.
H. Jang, Pearce, M. C., O'Donnell, E. F., Nguyen, B., Truong, L., Mueller, M. J., Bisson, W. H., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells”, Biology (Basel), vol. 6, no. 4, 2017.
J. Ochieng, Nangami, G. N., Ogunkua, O., Miousse, I. R., Koturbash, I., Odero-Marah, V., McCawley, L., Nangia-Makker, P., Ahmed, N., Luqmani, Y., and Bisson, W. H., “The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis”, Carcinogenesis, vol. 36, pp. S128–S159, 2015.
F. J. Gonzalez, Jiang, C., Bisson, W. H., and Patterson, A. D., “Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity”, Journal of hepatology, 2015.
C. Jiang, Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., Liu, Y., Gavrilova, O., Patterson, A. D., and Gonzalez, F. J., “Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction”, Nature Communications, vol. 6, p. 10166, 2015.
K
J. - I. Lee, Nian, H., Cooper, A. J. L., Sinha, R., Dai, J., Bisson, W. H., Dashwood, R. H., and Pinto, J. T., “ -Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells”, Cancer Prevention Research, vol. 2, no. 7, pp. 683 - 693, 2009.
L
W. H. Bisson, Scapozza, L., Westera, G., Mu, L., and Schubiger, P. A., “Ligand selectivity for the acetylcholine binding site of the rat $\alpha$4$\beta$2 and $\alpha$3$\beta$4 nicotinic subtypes investigated by molecular docking”, Journal of medicinal chemistry, vol. 48, pp. 5123–5130, 2005.
B. C. Goodale, La Du, J. K., Tilton, S. C., Sullivan, C. M., Bisson, W. H., Waters, K. M., and Tanguay, R., “Ligand-specific transcriptional mechanisms underlie aryl hydrocarbon receptor-mediated developmental toxicity of oxygenated PAHs”, Toxicological Sciences, p. kfv139, 2015.
B. C. Goodale, La Du, J., Tilton, S. C., Sullivan, C. M., Bisson, W. H., Waters, K. M., and Tanguay, R. L., “Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs.”, Toxicol Sci, vol. 147, no. 2, pp. 397-411, 2015.